期刊文献+

不同剂量固尔苏治疗40例新生儿呼吸窘迫综合征的临床研究 被引量:23

Clinical research on treatment of neonatal respiratory distress syndrome by different doses of curosurf in 40 Cases
下载PDF
导出
摘要 目的观察在并发有新生儿呼吸窘迫综合征(NRDS)的早产儿中,不同首次剂量固尔苏的临床效果。方法将胎龄小于36周,生后3d内诊断为早产儿呼吸窘迫综合征的40例患儿随机分为治疗组和对照组,前者在确诊NRDS后即给予固尔苏200mg/kg治疗,后者给予固尔苏100mg/kg治疗,若病情无明显改善可在每12小时后再次给予固尔苏100mg/kg,但总量不得超过400mg/kg。具有机械通气指征时均予行机械通气。结果治疗组患儿需要接受第2、3剂固尔苏治疗的比例以及平均机械通气时间。平均吸氧时间均低于对照组(P<0.05);治疗组血气分析结果较对照组明显改善(P<0.05);胸片结果也明显优于对照组;两组患儿严重并发症的累积发生率比较差异无统计学意义(P>0.05)。结论对于确诊为NRDS的早产儿,首次给予固尔苏治疗剂量(200mg/kg)可减少再次用药比例,改善患儿血气分析及胸片结果,缩短早产儿机械通气时间及氧疗时间,值得临床广泛推广。 Objective To observe the clinical effects of different first doses of curosurf in treating premature neonatal respiratory distress syndrome(NRDS).Methods 40 newborns with gestational age less than 36 weeks were diagnosed as NRDS within 3 d after born and divided into the therapy group and the control group.The therapy group was given curosurf 200mg/kg,while the control group was given curosurf 100 mg/kg,but the total dose did not exceed 400mg/kg.Results The ratio needing the second and third doses of curosurf,the average time of mechanical ventilation and oxygen inhalation in the therapy group were lower than those in the control group,showing statistical difference(P0.05).The results of chest X-ray in the therapy group also was obviously superior to the control group.The difference in cumulative incidence rate of complications had no statistical significance between two groups(P0.05).Conclusion Premature neonates diagnosed as NRDS receiving curosurf of 200 mg/kg as the first dose can decrease the ratio of receiving curosurf again,decrease the time of mechanical ventilation and oxygen inhalation,which is worth spreading in clinic.
出处 《重庆医学》 CAS CSCD 北大核心 2012年第6期559-560,563,共3页 Chongqing medicine
关键词 呼吸窘迫综合征 早产儿 固尔苏 respiratory distress syndrome newborn premature curosurf
  • 相关文献

参考文献7

二级参考文献44

  • 1谢俊刚,徐永健,张珍祥,倪望,陈仕新.肺泡表面活性物质相关蛋白A基因多态性与慢性阻塞性肺疾病易感性的关系[J].中华医学遗传学杂志,2005,22(1):91-93. 被引量:18
  • 2甘小庄,宋国维.欧洲和加拿大肺表面活性物质临床应用指南和建议[J].新生儿科杂志,2005,20(4):189-192. 被引量:33
  • 3于萍,王和,袁粒星.产前诊断技术及其临床应用[J].中国优生与遗传杂志,2007,15(4):14-17. 被引量:37
  • 4金汉珍 见:金汉珍 黄德珉 官希吉 主编.新生儿呼吸窘迫综合征[A].见:金汉珍,黄德珉,官希吉,主编.实用新生儿学:第3版[C].北京:人民卫生出版社,2003.421.
  • 5金汉珍.新生儿呼吸窘迫综合征[M].//金汉珍,黄德珉,官希吉.实用新生儿学.第3版.北京:人民卫生出版社,2003:421-427.
  • 6潘祥林.临床诊断的内容和格式[M]∥陈文彬,潘祥林,康熙雄,等.诊断学[M].第6版.北京:人民卫生出版社,2004:582-583.
  • 7[1]Wiswell TE.Expanded uses of surfactant therapy.Clin Perinatol,2001,28(3):695
  • 8[2]Findlay RD,Taeusch HW,Walther.Surfactant replacement therapy for meconium aspiration syndrome .Pediatrics,1996,97(1):48
  • 9[3]Lotze A,Mitcbell BR,Bulas DI,et al.Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure.J Pediatr,1998,132:40
  • 10[4]Wiswell TE,Knight GR,Finer NN,et al.A multicenter,randomized,controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome.Pediatrics,2002,109(6):1081

共引文献109

同被引文献133

引证文献23

二级引证文献147

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部